BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33414584)

  • 1. Role of autophagy in regulation of glioma stem cells population during therapeutic stress.
    Abbas S; Singh SK; Saxena AK; Tiwari S; Sharma LK; Tiwari M
    J Stem Cells Regen Med; 2020; 16(2):80-89. PubMed ID: 33414584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EMAP-II sensitize U87MG and glioma stem-like cells to temozolomide via induction of autophagy-mediated cell death and G2/M arrest.
    Yu Q; Liu L; Wang P; Yao Y; Xue Y; Liu Y
    Cell Cycle; 2017 Jun; 16(11):1085-1092. PubMed ID: 28436750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion of differentiated cancer cells into cancer stem-like cells in a glioblastoma model after primary chemotherapy.
    Auffinger B; Tobias AL; Han Y; Lee G; Guo D; Dey M; Lesniak MS; Ahmed AU
    Cell Death Differ; 2014 Jul; 21(7):1119-31. PubMed ID: 24608791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MIR93 (microRNA -93) regulates tumorigenicity and therapy response of glioblastoma by targeting autophagy.
    Huang T; Wan X; Alvarez AA; James CD; Song X; Yang Y; Sastry N; Nakano I; Sulman EP; Hu B; Cheng SY
    Autophagy; 2019 Jun; 15(6):1100-1111. PubMed ID: 30654687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell surface vimentin-targeted monoclonal antibody 86C increases sensitivity to temozolomide in glioma stem cells.
    Noh H; Zhao Q; Yan J; Kong LY; Gabrusiewicz K; Hong S; Xia X; Heimberger AB; Li S
    Cancer Lett; 2018 Oct; 433():176-185. PubMed ID: 29991446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ABT-888 enhances cytotoxic effects of temozolomide independent of MGMT status in serum free cultured glioma cells.
    Balvers RK; Lamfers ML; Kloezeman JJ; Kleijn A; Berghauser Pont LM; Dirven CM; Leenstra S
    J Transl Med; 2015 Feb; 13():74. PubMed ID: 25886061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of autophagy increases susceptibility of glioblastoma stem cells to temozolomide by igniting ferroptosis.
    Buccarelli M; Marconi M; Pacioni S; De Pascalis I; D'Alessandris QG; Martini M; Ascione B; Malorni W; Larocca LM; Pallini R; Ricci-Vitiani L; Matarrese P
    Cell Death Dis; 2018 Aug; 9(8):841. PubMed ID: 30082680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repurposing FDA approved drugs inhibiting mitochondrial function for targeting glioma-stem like cells.
    Datta S; Sears T; Cortopassi G; Woolard K; Angelastro JM
    Biomed Pharmacother; 2021 Jan; 133():111058. PubMed ID: 33378970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia-induced galectin-8 maintains stemness in glioma stem cells via autophagy regulation.
    Liu D; Zhu H; Cheng L; Li R; Ma X; Wang J; Wang J; Zhang S; Li Y; Shu K; Yu X; Li C
    Neuro Oncol; 2024 May; 26(5):872-888. PubMed ID: 38158714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicardipine sensitizes temozolomide by inhibiting autophagy and promoting cell apoptosis in glioma stem cells.
    Shi J; Dong X; Li H; Wang H; Jiang Q; Liu L; Wang L; Dong J
    Aging (Albany NY); 2021 Feb; 13(5):6820-6831. PubMed ID: 33621205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glioblastoma stem cells (GSCs) epigenetic plasticity and interconversion between differentiated non-GSCs and GSCs.
    Safa AR; Saadatzadeh MR; Cohen-Gadol AA; Pollok KE; Bijangi-Vishehsaraei K
    Genes Dis; 2015 Jun; 2(2):152-163. PubMed ID: 26137500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sitagliptin inhibits the survival, stemness and autophagy of glioma cells, and enhances temozolomide cytotoxicity.
    You F; Li C; Zhang S; Zhang Q; Hu Z; Wang Y; Zhang T; Meng Q; Yu R; Gao S
    Biomed Pharmacother; 2023 Jun; 162():114555. PubMed ID: 36966667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glioblastoma stem cell (GSC)-derived PD-L1-containing exosomes activates AMPK/ULK1 pathway mediated autophagy to increase temozolomide-resistance in glioblastoma.
    Zheng Y; Liu L; Wang Y; Xiao S; Mai R; Zhu Z; Cao Y
    Cell Biosci; 2021 Mar; 11(1):63. PubMed ID: 33789726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivo.
    Signore M; Pelacchi F; di Martino S; Runci D; Biffoni M; Giannetti S; Morgante L; De Majo M; Petricoin EF; Stancato L; Larocca LM; De Maria R; Pallini R; Ricci-Vitiani L
    Cell Death Dis; 2014 May; 5(5):e1223. PubMed ID: 24810059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric Oxide Prevents Glioblastoma Stem Cells' Expansion and Induces Temozolomide Sensitization.
    Salvatori L; Malatesta S; Illi B; Somma MP; Fionda C; Stabile H; Fontanella RA; Gaetano C
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular sphingosine-1-phosphate: a novel actor in human glioblastoma stem cell survival.
    Riccitelli E; Giussani P; Di Vito C; Condomitti G; Tringali C; Caroli M; Galli R; Viani P; Riboni L
    PLoS One; 2013; 8(6):e68229. PubMed ID: 23826381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demethoxycurcumin was superior to temozolomide in the inhibition of the growth of glioblastoma stem cells in vivo.
    Leng L; Zhong X; Sun G; Qiu W; Shi L
    Tumour Biol; 2016 Oct; ():. PubMed ID: 27757851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Development and Applications of a Dual Optical Imaging System for Studying Glioma Stem Cells.
    Tai PA; Liu YL; Wen YT; Lin CM; Huynh TT; Hsiao M; Wu ATH; Wei L
    Mol Imaging; 2019; 18():1536012119870899. PubMed ID: 31478435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neural stem/progenitors and glioma stem-like cells have differential sensitivity to chemotherapy.
    Gong X; Schwartz PH; Linskey ME; Bota DA
    Neurology; 2011 Mar; 76(13):1126-34. PubMed ID: 21346220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone morphogenetic protein 7 sensitizes O6-methylguanine methyltransferase expressing-glioblastoma stem cells to clinically relevant dose of temozolomide.
    Tso JL; Yang S; Menjivar JC; Yamada K; Zhang Y; Hong I; Bui Y; Stream A; McBride WH; Liau LM; Nelson SF; Cloughesy TF; Yong WH; Lai A; Tso CL
    Mol Cancer; 2015 Nov; 14():189. PubMed ID: 26546412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.